文献速递膀胱癌与上尿路尿路上皮癌

尿液微生物组全球荟萃分析:膀胱癌患者中多环芳烃降解菌的定植

Global Meta-analysis of Urine Microbiome: Colonization of Polycyclic Aromatic Hydrocarbon-degrading Bacteria Among Bladder Cancer Patients.
PubMed 文献 · Eur Urol Oncol · 2023-03-01

该研究整合三项已发表膀胱癌尿液微生物组研究与本中心前瞻性队列,共129例膀胱癌尿液和60例健康对照样本,跨四个国家。采用机器学习算法分析发现,去除采集方法相关污染物后,膀胱癌患者尿液中多环芳烃降解菌(鞘氨醇单胞菌属、不动杆菌属、微球菌属、假单胞菌属和拉尔斯通菌属)丰度 consistently 增高。

要点

  • 膀胱癌患者尿液微生物组中97/548个属与健康对照存在差异丰度。
  • 仅用中国、匈牙利和克罗地亚数据集无法区分膀胱癌与健康成人(AUC 0.577)。
  • 纳入导尿样本后膀胱癌预测诊断准确率提高至AUC 0.995,精确率-召回率AUC=0.994。

核心结论

  • 膀胱癌人群的微生物群可能反映来自吸烟、环境污染物和摄入的多环芳烃暴露。
  • 膀胱癌患者尿液中多环芳烃的存在可能提供独特的代谢生态位和必要的代谢资源,使其他细菌无法繁殖。
  • 组成差异与地理位置的关联大于与疾病的关联,但许多差异由采集方法驱动。

研究设计与样本

  • 下载三项已发表膀胱癌尿液微生物组研究的原始FASTQ文件,并纳入本中心前瞻性收集的队列。
  • 使用QIIME 2020.8平台进行解复用和分类,uCLUST算法以97%序列相似性聚类操作分类单元,针对Silva RNA序列数据库在门水平分类。
  • 利用三项研究的可用元数据,通过metagen R函数的随机效应荟萃分析评估膀胱癌患者与对照的差异丰度。
  • 使用SIAMCAT R包进行机器学习分析。
  • 研究纳入四个不同国家的129例膀胱癌尿液和60例健康对照样本。

主要发现

  • 在膀胱癌尿液微生物组中,共鉴定出97/548个属与健康患者相比存在差异丰度。
  • 多样性指标的差异主要围绕原产国聚集(Kruskal-Wallis,p < 0.001),采集方法是微生物组组成的驱动因素。
  • 评估中国、匈牙利和克罗地亚数据集时,数据对区分膀胱癌患者与健康成人无判别能力(AUC 0.577)。
  • 纳入导尿样本后,膀胱癌预测诊断准确率提高至AUC 0.995,精确率-召回率AUC = 0.994。
  • 通过消除所有队列中与采集方法相关的污染物,研究鉴定出多环芳烃降解菌鞘氨醇单胞菌属、不动杆菌属、微球菌属、假单胞菌属和拉尔斯通菌属在膀胱癌患者中持续存在且丰度增加。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The application of next-generation sequencing techniques has enabled characterization of urinary tract microbiome. Although many studies have demonstrated associations between the human microbiome and bladder cancer (BC), these have not always reported consistent results, thereby necessitating cross-study comparisons. Thus, the fundamental questions remain how we can utilize this knowledge. OBJECTIVE: The aim of our study was to examine the disease-associated changes in urine microbiome communities globally utilizing a machine learning algorithm. DESIGN, SETTING, AND PARTICIPANTS: Raw FASTQ files were downloaded for the three published studies in urinary microbiome in BC patients, in addition to our own prospectively collected cohort. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Demultiplexing and classification were performed using the QIIME 2020.8 platform. De novo operational taxonomic units were clustered using the uCLUST algorithm and defined by 97% sequence similarity and classified at the phylum level against the Silva RNA sequence database. The metadata available from the three studies included were used to evaluate the differential abundance between BC patients and controls via a random-effect meta-analysis using the metagen R function. A machine learning analysis was performed using the SIAMCAT R package. RESULTS AND LIMITATIONS: Our study includes 129 BC urine and 60 healthy control samples across four different countries. We identified a total of 97/548 genera to be differentially abundant in the BC urine microbiome compared with that of healthy patients. Overall, while the differences in diversity metrics were clustered around the country of origin (Kruskal-Wallis, p < 0.001), collection methodology was a driver of microbiome composition. When assessing dataset from China, Hungary, and Croatia, data demonstrated no discrimination capacity to distinguish between BC patients and healthy adults (area under the curve [AUC] 0.577). However, inclusion of samples with catheterized urine improved the diagnostic accuracy of prediction for BC to AUC 0.995, with precision-recall AUC = 0.994. Through elimination of contaminants associated with the collection methodology among all cohorts, our study identified increased abundance of polycyclic aromatic hydrocarbon (PAH)-degrading bacteria Sphingomonas, Acinetobacter, Micrococcus, Pseudomonas, and Ralstonia to be consistently present in BC patients. CONCLUSIONS: The microbiota of the BC population may be a reflection of PAH exposure from smoking, environmental pollutants, and ingestion. Presence of PAHs in the urine of BC patients may allow for a unique metabolic niche and provide necessary metabolic resources where other bacteria are not able to flourish. Furthermore, we found that while compositional differences are associated with geography more than with disease, many are driven by the collection methodology. PATIENT SUMMARY: The goal of our study was to compare the urine microbiome of bladder cancer patients with that of healthy controls and evaluate any potential bacteria that may be more likely to be found in patients with bladder cancer. Our study is unique as it evaluates this across multiple countries, to find a common pattern. After we removed some of the contamination, we were able to localize several key bacteria that are more likely to be found in the urine of bladder cancer patients. These bacteria all share their ability to break down tobacco carcinogens.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Bukavina L, Isali I, Ginwala R, et al. Global Meta-analysis of Urine Microbiome: Colonization of Polycyclic Aromatic Hydrocarbon-degrading Bacteria Among Bladder Cancer Patients. Eur Urol Oncol. 2023. PMID: 36868921. doi:10.1016/j.euo.2023.02.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。